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ABSTRACT OF THESIS 
 
 
 
APPROACHES TO MOLECULAR IMPRINTING ON POLYSILOXANE 
SCAFFOLDS 
 
Molecular imprinting, a common method used in separations and 
chromatography to isolate specific molecules via surface binding, has been 
adapted for applications in biomaterials and related sciences.  The objective of 
this study was to determine the effectiveness of different approaches to 
molecular imprinting by testing for preferential binding of protein on polysiloxane 
scaffold surfaces.  To test preferential rebinding, the scaffolds were exposed to a 
mixture of the template protein and a competitor protein with similar size but 
different chemistry.  Lysozyme-imprinted polymers rebound 8.13 ± 0.99% of 
lysozyme without any competition and 5.1 ± 0.3% of the protein during 
competition.  Lysozyme C peptide was imprinted into polysiloxane scaffolds to 
investigate the “epitope approach” to molecular imprinting.  Without competition, 
8.95 ± 11.53% of the lysozyme preferentially bound to the scaffolds, while under 
competition 1.85 ± 9.47% bound to the scaffolds.  Lastly, bone morphogenetic 
protein 2 (BMP-2) was imprinted into the polymer scaffolds.  Results revealed 
that BMP-2 imprinted scaffolds bound 10.09 ± 6.625% under noncompetitive 
conditions and a very small 0.65 ± 4.55% during competition.  Trends of 
preferential binding via peptide imprinting and BMP-2 imprinting can be seen, 
and show promise in future tissue engineering material applications and 
biomaterial compatibility. 
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1. Introduction 
The advancement in treatment of human bone damage has reached an 
astonishing level.  In understanding the mechanisms of bone healing and 
formation, medicine has climbed to a position where most bone dysfunctions and 
injuries can be reasonably remedied.  For cases such as a simple fracture, bone 
is stabilized and allowed to heal itself.  Extensive bone damage resulting from 
comminuted and compound fractures are repaired using devices geared toward 
internal methods, such as pins, that hold bone together or implants that replace 
the tissue.  Many bone biomaterials, such as metal, ceramic, polymer, and 
composite implants, now play an integral part in repairing bone and cartilage 
function [1].  Despite these advances, there is still a need for a more efficient 
method of bone repair that circumvents the problems created by conventional 
procedures, such as bio-incompatibility, premature failure, harmful invasive 
surgery, and costs. 
Tissue engineering, a recently developed field of science, brings a new 
hope for not only tissue repair but regeneration [2].  The concept involves 
growing new and healthy tissue when normally the body could not do so 
otherwise using a sophisticated strategy with biomolecules, cells, and a scaffold 
matrix.  The combination of biology and engineering has already led to incredible 
breakthroughs in clinical studies including skin and cartilage tissue replacement 
[3].  Among the various methods of protein immobilization, molecularly imprinted 
polymers (MIPs) have been recently investigated and used for many 
applications.  Polymers such as polyacrylics and silicas are polymerized with 
biomolecules that when removed, form an imprint mimicking its identical shape 
and chemical arrangement [4].  The key ability of the MIP is to rebind what it has 
imprinted when it is exposed to a biological system. 
In the past, MIPs have been used for imprinting simple biomolecules, such 
as sugars, steroids, certain drugs and pesticides [5].  Not until recently have 
larger biomolecules, such as proteins been used with MIPs for many applications 
such as molecular recognition assays [4, 6, 7].  Among countless other purposes, 
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cells use protein as extracellular cues to start attachment, differentiation, 
communication, and intracellular processes.  In this light, proteins can be 
selectively adhered to MIPs for the purpose of controlled cellular behavior, from 
cell adhesion to eventual matrix construction and tissue growth. 
The aim of this study, therefore, was two-fold.  The first was to investigate 
the potential for molecular imprinting using two types of molecules, one being the 
protein and the other a peptide found on its surface.  Protein imprinting has been 
seen in studies, but whether or not imprinting with just a small peptide section of 
it produces the same binding preference has not been studied in great detail.  
Secondly, bone morphogenetic protein 2 (BMP-2), a protein found to be an 
important growth factor in osteogenesis, was investigated for its potential in 
preferential binding to polysiloxanes MIPs for controlled cellular behavior in vitro. 
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2. Background and Significance 
2.1. Current Approaches to Meeting the Need for Bone Repair 
A major interest among the medical field is the need for optimization of 
bone damage repair.  In most cases of bone damage therapy, the degree of 
treatment depends on the severity of the injury or defect.  For a simple injury 
such as a linear fracture in a bone, a closed reduction treatment is applied [8-10].  
In this instance, the fracture is reduced by natural bone healing through external 
stabilization techniques, such as a plaster cast [11, 12].  As long as the bone 
ends are united and micromotion is avoided, healing of the fracture will result in a 
minimal loss of function.  For a complex bone injury that produces segmented 
bone, bone fragments, or large voids in the tissue, a more intricate approach is 
necessary for replacing normal function.  Open reduction involves reducing 
fractures through the use of careful surgery.  In a case where the bone has been 
shattered, the affected area is cut open and nails are usually used in conjunction 
with metal rods and plates to piece the tissue back into its proper place so that 
the bone can be healed in the correct position [12, 13] (Figure 1).  Displaced 
fractures have a high incidence of avascular necrosis, pseudoarthrosis (a fake 
joint), and refracture [14].  In any case, mild fractures when treated properly and 
allowed a period of decreased activity, will result in rapid healing, and return to 
full activity, whereas more severe fractures will require more intervention and a 
longer recovery period [14]. 
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Figure 1.  The use of an llizarov frame for bone transport in an infected nonunion 
of an open tibia fracture [11]. 
 
Oftentimes, injury or disease can cause voids in the bone beyond a 
certain “critical size”, such that complete calcification of the wound will not occur 
[15].  In a mathematical model developed by J.S. Arnold, the range for a 
reasonable estimate of the critical size defect is from 0.4 cm up to 1.5 cm for 
animals such as rats, rabbits, dogs, pigs, and monkeys [15].  These voids can 
come from implant failure [16], serious bone trauma, and disease like 
osteoporosis and cancer where the structure of the bone becomes increasingly 
susceptible to damage [17, 18].  New approaches involving bone grafting and 
tissue engineering are now under investigation for solving large void volume 
problems.  These new techniques have the ability to grow new bone tissue using 
the strategic involvement of biology and materials engineering [19].  Grafting of a 
patient’s own bone is ideal from the perspective of rejection and osteogenic 
potential while producing the best clinical results [20].  Ideally, tissue engineering 
will enable bone growth to bridge the gap and replace the large void that was 
once unfixable with natural tissue [21].  
4 
 Tissue engineering techniques are quite new and still under rigorous 
study.  The reason why these methods of bone healing are so sought after is 
their efficiency of restoring proper bone tissue and function.  In fact, such 
methods may be able to replace bone tissue in places where before it has been 
impossible. 
2.2. Wound Healing in Bone 
 
In order to optimize the performance of a bone biomaterial, it is important 
to understand the physiology behind natural bone tissue.  The most successful 
implant or bone graft is the one that best utilizes the natural properties and 
components of bone [22].  The process in which bone heals and regenerates is, 
therefore, crucial in the development of a material that helps in replacing bone 
tissue function [23]. 
The wound healing process is initiated immediately after a fracture has 
occurred or a defect is created in the bone tissue [24].  The first course of action 
is exudation of fluid and protein to the injured site [10].  Neutrophils and 
macrophages begin to clean up the wound by identifying small foreign objects 
and small fragments of bone.  Platelets are concentrated at areas of damaged 
blood vessels to induce hemostasis and blood clotting.  After a short time, the 
damaged tissue site becomes inflamed and induces chemical mediators such as 
proteases, cytokines, and growth factors [25].  Continual clotting creates a 
fracture hematoma where fibroblasts and macrophages are recruited [10].  
Fibroblasts produce new collagen fibers and an aggregate of loose cells 
interspersed with new blood vessels (granulation tissue) while the macrophages 
engulf any harmful biomolecules  [26, 27].  Concurrently, cells of the periosteum 
begin to replicate and differentiate, many of which have osteogenic potential.  
These cells migrate to the wound and transform into specialized cells, each 
playing a specific role in bone regeneration [10] (Figure 2).  Dead bone 
fragments around the site are resorbed and dissolved by osteoclasts, while 
osteoblasts produce new trabeculae which eventually become spongy bone and 
later compact bone [28].  The differentiation of osteogenic cells into osteoblasts 
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is triggered by the abundance of many localized growth factors, such as 
fibroblast growth factor (FGF), prostaglandins, and transforming growth factor 
beta (TGF-β) [29, 30].  Released due to the wound healing response during 
inflammation, BMP-2, a member of the TGF-β family of growth factors, has been 
shown to repair and induce bone formation [30].  It is for this reason that BMP-2 
is so widely studied in bone grafting and implant compatibility. 
 
 
Figure 2.  Steps of the bone healing process [10]. 
 
2.3. General Tissue Engineering Concepts 
 
Tissue engineering is a widely studied approach for bodily tissue and 
organ replacement therapies.  It involves growing or repairing the tissue in a host 
using a combination of components found in the natural physiological 
environment and a biomimetic material that is recognized by cells via chemical or 
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physical methods [31].  Tissue engineering is accomplished under the use of 
three main components: 1.) protein or other biomolecules that are specific in 
function, 2.) cells which are used in tissue regeneration, and 3.) an extracellular 
matrix which is mimicked by a porous scaffold [3, 32] (Figure 3).  The type and 
amount of protein and biomolecules incorporated in the engineered scaffold, as 
well as the surface characteristics (i.e., chemistry and roughness) of the implant 
will have a profound influence on cell type migration and proliferation [33] .  Since 
a biomaterial is considered a foreign object inside the body, certain proteins 
attached to the scaffold matrix may help in reducing an immune response [26].  
Cells are a crucial element in tissue engineering because they begin the 
manufacture of tissue.  Once a cell is able to safely attach, it begins producing 
growth factors that acts as a communicator for other cells to attach and migrate 
to the site [18].  Eventually, chemical mediators in the system begin to signal for 
the cells to differentiate into specific cell types that start producing the building 
blocks of new tissue.  The scaffold used in tissue engineering techniques is of 
particular importance because it has several significant functions.  For one, the 
scaffold may act as a temporary mechanical replacement for the original tissue 
such as in bone or cartilage [26].  Secondly, the porous nature of the scaffold 
allows cells to infiltrate into the pores and proliferate much like in native tissue 
[21].  Attachment and controlled activity of the cells can also be achieved with 
greater success by incorporating proteins and biomolecules into the scaffold’s 
lattice structure [34].  In the case of a biodegradable bone scaffold matrix, 
structural function is slowly transferred to the new bone while the temporary 
biomaterial degrades away, thereby growing completely new permanent tissue 
without still having foreign material in the body [35].  These types of scaffolds are 
made from both natural (i.e., collagen, fibrin) and synthetic polymer (i.e., 
poly(lactic-co-glycolic acid)) materials [26]. 
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Figure 3.  The basic concept of tissue engineering [3]. 
 
2.4. Basic Protein Characteristics 
 
Proteins are of great importance for both tissue engineering 
efficiency and controlling overall cellular behavior.  It has been shown that 
signaling proteins control the cellular behaviors associated with tissue formation. 
Understanding the underlying principles of proteins are crucial for an effective 
collaboration between a biomaterial and controlled cellular activity [36].  The very 
basic unit of a protein is the amino acid.  A chain of amino acids in a particular 
sequence are what make up a polypeptide, or a protein’s primary structure.  As 
the peptide chain grows in length, the functional groups that make up the amino 
acids begin to interact with each other, bending and twisting the chain into what 
is known as the protein’s secondary structure.  Common forms of the secondary 
structure are the alpha helix and the beta sheet.  Continual growth of the chain 
induces a larger number of intramolecular interactions where secondary 
structures are now greatly affected by each other.  The result forms a tertiary 
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structure, which describes how the entire protein molecule coils into an overall 
three-dimensional shape.  Quaternary structures may be attained with some but 
not all proteins by bonding and chemically interacting between different 
polypeptide chains in the molecules [10, 37]. 
Because of their chemical constitution, proteins have a tendency to bind to 
many surfaces.  In most cases, when a material is exposed to the blood stream, 
many small proteins will instantly adhere to the surface non-specifically [23].  
This adhesion is created by electrostatic forces and hydrophobic interactions 
from the chemistry of the protein and the surface chemistry of the biomaterial 
[38].  Specific adsorption occurs when the surface of a material binds protein 
using specialized spatial or chemical devices such as a cell receptor or 
extracellular matrix biomolecules.  In such cases, molecular bonds like hydrogen 
bonding and ionic bonding are involved in the ligand-receptor complex [26]. 
As mentioned before, while non-specific adsorption relates to random 
protein placement, specific adhesion relates to selective placement, which is 
crucial because of the effects protein has at the cellular level.  Figure 4 shows a 
schematic of the BMP-2 protein and receptor complex.  When a particular protein 
is present in the vicinity of a cell, binding of the protein via a specific surface 
receptor will induce a cascade of events that will change the activity of the cell 
[39].  As previously discussed, BMP-2 is a member of the transforming growth 
factor family that plays an important role in bone healing.  When bound to the 
surface receptor, the protein induces differentiation of resident mesenchymal 
cells into bone cells [40].  Similar to an enzyme binding a substrate, the BMP-2 
receptor on the cell’s surface will only recognize the specific shape and chemistry 
of BMP-2.  Once binding of the protein occurs, a series of intracellular events 
takes place that result in the cell’s maturation.  The signaling cascade starts 
when BMP-2 contacts the BMP receptors.  Phosphorylation of the receptor 
protein forms the transducing complex, which phosphorylates the Smad proteins 
(i.e. Smad-1, Smad-5, and Smad-8).  Smad-1 and Smad-5 enter the nucleus of 
the mesenchymal cell after interacting with Smad-4 and initiate the BMP 
response genes.  Smad-6 and Smad-7 inhibit phosphorylation of Smad-5, while 
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noggin and chordin, are BMP antagonists and prevent receptor binding [41] 
(Figure 5). 
 
 
Figure 4.  A diagram of bone morphogenetic protein 2 (BMP-2) bound to its cell 
receptor BMP receptor type IA (BRIA) [42]. 
 
 
Figure 5.  The BMP intracellular and signaling cascade [41]. 
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2.5. Molecular Imprinting 
 
As a way of creating a material with specific protein adsorption properties, 
molecular imprinting has been developed through years of study.  The process 
involves the fabrication of a material with molecular structures initially embedded 
in the biomaterial.  When the molecules on the surface are removed, they leave 
behind a crevice with the same physical shape.  In addition, the same spatial 
orientation of complementary chemical groups that bound the molecule in the 
material is preserved.  As a result, the same molecule (or ‘template’) used to 
make the imprint is able to specifically rebind even under environments that 
contain other competing molecules (or ‘competitor’) [6, 43, 44].  
The most common molecularly imprinted materials are polymers due to 
their ability to chemically cross-link the template molecule.  In general, these 
polymers, termed molecularly imprinted polymers (MIPs), are formed from: 1.) a 
cross-linking agent, 2.) a functional monomer, and 3.) the template molecule 
(Figure 6).  The template molecule is mixed with the functional monomer so that 
chemical bonds between the two are formed.  The cross-linking agent binds to 
the functional monomers upon polymerization, which embeds the template 
molecule in a polymer matrix.  The molecules that are embedded on the surface 
when removed are the primary contributors to the imprints.  Because the 
functional monomers are bound to the template in a specific position within the 
polymer, removal of the molecule will result in an imprint with both spatial and 
chemical preservation.  Now, the structure of the polymer at this location is a 
mirror of the template molecule and is able to rebind that molecule preferentially 
over other competitor molecules that do not share the same physical and 
chemical structure [4, 43, 45].  
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Figure 6.  Schematic generalization of the molecular imprinting process [46]. 
 
In the early history of MIPs, small biomolecules, such as sugars, 
cholesterols, and certain drugs, were used as a template because of their 
simplicity and stability.  Recently however, proteins have been the focal point of 
many MIP studies for uses in biomaterial compatibility, medical diagnostics, drug 
delivery, and tissue engineering [5].  The chemical structure of protein consisting 
of several functional groups allows many binding opportunities for a variety of 
functional monomers, provided the interaction is on the surface of the molecule.  
Polymerization of the protein is usually safe under tolerable conditions, and 
removal of the protein can be accomplished using a protease to digest the 
protein while keeping the functional monomers intact for rebinding.  Unlike the 
simple template molecules used before it, however, protein as a template 
produces quite a few problems.  Because proteins are large, sensitive, and 
unstable molecules, imprinting with these molecules can be very difficult [7].  
Conditions such as pH, pressure, and temperature can have an influence on the 
protein’s structure at the time of polymerization and create errors in the imprinting 
process.  The protein’s flexible structure also makes it difficult to achieve efficient 
and consistent binding results [4].  In other words, the physical shape of the 
protein may bend or stretch from other obstacles, such as biomolecules or 
movement of the surrounding fluid, creating a form unrecognizable to the rigid 
surface of the material.  Many studies are currently underway to address these 
problems by developing newer methods of imprinting (i.e., [47, 48]).  For 
instance, hydrogels are being studied in drug delivery applications for alterations 
in gel characteristics in response to factors such as pH, temperature, and ionic 
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strength of a solution.  A gel that can modify its swelling behavior can in turn alter 
its ability to bind molecules. 
While imprinting MIPs with protein is becoming a popular concept, a new 
approach to protein imprinting, called the epitope approach, is being explored [5] 
(Figure 7).  The epitope approach is so named due to its similarity in concept of 
the antigen-antibody complex.  When an antibody of the immune system binds a 
specific antigen, it does not need to recognize the presence of the entire 
molecule, but rather only a small portion of it.  This small peptide sequence on 
the antigen, called the epitope, is the site where the antibody specifically binds 
and influences an immune response.  Likewise, it may be possible to bind a large 
macromolecule such as a protein to a surface with only using a small peptide or 
‘epitope’ section [5].  In a MIP, a peptide sequence on the surface of the protein 
is isolated and imprinted into the material.  When the original protein is exposed 
to the imprint, the small peptide on its surface that was imprinted recognizes its 
spatial and chemical mimic in the polymer and binds.  In this fashion, only a 
portion of the entire molecule is needed for preferential binding, which shows 
potential for optimization of protein immobilization.  Figure 8 shows a schematic 
that illustrates a comparison between protein and peptide imprinting. 
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Figure 7.  Schematic representation of the epitope approach [5]. 
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Figure 8.  Comparison of whole protein and peptide imprinting on polysiloxane 
scaffolds. 
 
2.6. Sol-gel Processing 
 
In general, polymers are great materials for use in biological systems 
because they are stable, biocompatible, can be made of natural components, 
and have a structure that can be manipulated easily for different applications.  
Some polymers, such as poly(lactic-co-glycolic acid) (PLGA), can be used in 
drug delivery as degradable chemical carriers, while other polymers like 
hydrogels can be used as tissue replacements because of their gel-like 
properties and high water content.  Poly(methylmethacrylate) (PMMA) is a 
polymer widely used as bone cement because of the strong bonds made during 
polymerization between an implant material and bone tissue [26]. 
Polymers make great molecular imprinting materials because of the way 
they recognize the template molecule.  The chemistry of the polymer allows for 
15 
organization of the complementary functional groups in the template and the 
formation of the shape-selective cavity that is complementary to the template 
[49].  The kind of polymer used and the mechanism in which the template 
molecule is entrapped and dissociated from the imprint varies widely throughout 
many studies.  Polysiloxanes, a common family of inorganic polymers, are used 
as excellent MIPs because of their ease of fabrication, good molecule imprinting, 
and high template recognition.  In one study, investigated by Venton and Gutipati 
[50], it was observed that the silica based monomers tended to associate well 
with the functional groups on the protein during polymerization.  Removal of the 
protein led to complimentary ‘binding pockets’ in the polymer that allowed 
rebinding of the bovine serum albumin (BSA) protein. 
Sol-gel processing is one technique used in fabricating amorphous 
inorganic polymers.  The advantage of using sol-gel processing is that integration 
of the template molecule into the polymer is done easily and the polymerization 
process takes only a matter of seconds.  The term sol-gel comes from the idea of 
transitioning the liquid mixture solution of colloidal particles (sol) into an 
interconnected polymer network (gel) [51].  The process requires a mixture of two 
solutions, the first being a cross-linking agent, and the second containing the 
functional monomer and template molecule.  When the two are combined, the 
reaction mixture undergoes several polymerization steps [52, 53].  First, a 
hydrolysis reaction replaces alkoxide groups with hydroxide groups.  Next, 
through alcohol condensation and water condensation, silanol bonds (Si-OH) 
become siloxane bonds (Si-O-Si) [53] (Figure 9).  The growing siloxane bonds 
create a polymer network through polycondensation that incorporate the 
functional monomers and template molecules into the bulk material, entrapping 
water in the process to form a gel.  Aging and then drying of the polymer results 
in evaporation of the liquid and the production of a strong, brittle material [52]. 
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Figure 9.  Chemical steps of sol-gel processing to form polysiloxane.  A. 
Hydrolysis of the alkoxide groups.  B. Conversion of silanol bonds into siloxane 
bonds via condensation.  C. Polycondensation of alkoxisilanes to form 
interconnected network [53]. 
 
2.7. Significance 
 
While solutions exist for repairing defects in bone tissue due to injury and 
disease, there is still much room for improvement in this area of medicine.  
Tissue engineering and bone tissue grafting are current approaches to 
addressing these problems.  In these techniques, bone tissue is replaced by 
strategically influencing the body’s own regenerative abilities instead of using 
foreign material which may cause complications.  In order for bone grafting to be 
effective, it must utilize the physiological system properly and invoke a controlled 
biological response.  This can be done by altering the properties of the 
biomaterial at hand to immobilize specific biomolecules for a desired outcome.  
One way of immobilizing protein on the surface of polysiloxane scaffolds for 
controlled cellular behavior is by using molecular imprinting.  Molecular imprinting 
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allows specialized crevices to preferentially rebind a template protein because of 
their complementary spatial and chemical orientation of certain functional groups.  
Specialized imprints are created from embedding the protein on the surface of 
the material during polymerization of the polysiloxane and safely digesting it. 
Although molecular imprinting has been proven suitable using imprints 
with small biomolecules, approaches utilizing protein relevant to bone physiology, 
such as BMP-2, and preferentially binding protein via peptide imprints (the 
‘epitope’ approach), have not been fully explored.  Therefore, the objectives of 
this study were to: 1.) Discern if imprinting polysiloxane scaffolds with a peptide 
(lysozyme C peptide) could preferentially bind the  protein (lysozyme) just as well 
or better than imprinting with just the protein, 2.) Determine if preferential binding 
of BMP-2 via imprinting polysiloxane scaffolds can be accomplished, and 3.) 
Determine if preferential binding of BMP-2 on polysiloxane scaffolds invokes a 
controlled cellular response. 
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3. Methods and Materials 
3.1. Purifying BMP-2 
 
Bone morphogenetic protein 2 (BMP-2) was used in the study because of 
its ability to induce osteoblast differentiation and bone formation.  BMP-2 (Human 
Recombinant 85%, 11.989kDa, 1mg, Kamiya Biomedical Company) was found to 
have contained human serum albumin (HSA).  The protein sample must contain 
only BMP-2 in order to ensure imprinting of purely the template molecule.  First, 
the BMP-2 was suspended in 1mL of 0.1M carbonate-bicarbonate (carb-bicarb) 
buffer pH 8.5.  The solution was then broken up into eight aliquots of 125μL each 
into small microcentrifuge tubes.  The albumin was then removed from the 
protein samples using the SwellGel Blue Albumin Removal Kit protocol (Pierce).  
The resulting filtered protein samples were collected into one tube and if 
necessary suspended to 1mL using carb-bicarb buffer. 
3.2. Fluorescent Labeling 
 
In order to determine the amount of protein bound on the surface of the 
polymer scaffolds, all protein and peptides used in the imprinting experiments 
were fluorescently labeled with Invitrogen’s Amine-Reactive Probes.  Lysozyme, 
BMP-2, and lysozyme C peptide were labeled with Alexa Fluor 350, ribonuclease 
A (RNase A) and trypsin were labeled with Alexa Fluor 594, and other batches of 
lysozyme and BMP-2 were labeled with Alexa Fluor 488.  Proteins labeled with 
Alexa Fluor 350 were initially embedded within the polymer scaffolds and later 
released to quantify the amount that was imprinted on the surface.  Proteins 
labeled with Alexa Fluor 594 were the competitor molecules competing with the 
template proteins labeled with Alexa Fluor 488 for available surface binding sites. 
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3.2.1. Labeling Lysozyme C Peptide 
 
The peptide used in the imprinting experiments was Lysozyme C (46-61) 
(chicken) with a molecular weight of 1753.84Da (Bachem).  The peptide was first 
suspended in 1mL of 0.1M carb-bicarb buffer pH 8.5 to make a 5mg/mL solution.  
The Alexa Fluor 350 dye was suspended in dimethyl sulfoxide (DMSO) at 
1mg/100µL.  The Invitrogen protocol called for 50µL of the 10mg/mL dye solution 
to be mixed with a protein solution of 5-20mg/mL.  Since 1mL of a 5mg/mL stock 
of the peptide was available, only 400µL was used.  The 50μL of Alexa Fluor dye 
was slowly added to the peptide mix.  The resulting mixture consisted of 450µL of 
liquid, which was covered in aluminum foil, shaken, and mixed for one hour in a 
small 1.5mL centrifuge tube on an orbital shaker in order to allow binding of the 
fluorescent dye to the protein.  Next, the liquid was transferred to a dialysis 
pouch filter (Slide-A-Lyzer Dialysis Cassette 2000 MWCO 0.2-0.5mL capacity, 
Pierce) via a 20 gauge syringe.  The pouch containing the unfiltered protein 
solution was suspended in a beaker with a volume of carb-bicarb buffer 500 
times the volume of the pouch (225mL) and was left covered in aluminum foil for 
three periods of 2 hours each.  In between periods the outer volume was 
replaced with fresh carb-bicarb buffer.  For the last period, the beaker was placed 
in a 4°C refrigerator overnight covered in aluminum foil.  After dialysis, the 
labeled peptide was removed via syringe and placed in a 1.5mL centrifuge tube 
for storage in a -20°C freezer. 
3.2.2. Labeling Lysozyme and Bone Morphogenetic Protein 2 
 
Lysozyme protein (from chicken egg white, Sigma) and BMP-2 were 
labeled much in the same way as the lysozyme C peptide.  To suspend the solid 
protein, 20mg of lysozyme was mixed in 1mL of carb-bicarb buffer to form a 
concentration of 20mg/mL, while 1mL of carb-bicarb buffer was dispensed in the 
BMP-2 storage tube.  Since lysozyme and BMP-2 are used for imprinting the 
polymer as well as testing for preferential binding, two different fluorescent labels 
were tagged to the protein.  Aliquots of 50µL of Alexa Fluor 350 and 50µL of 
20 
Alexa Fluor 488 were slowly mixed with two separate solutions (four solutions 
total) of the 20mg/mL lysozyme mix and 250 μL of the BMP-2 stock (after purified 
of albumin) and shaken for 1 hour covered with aluminum foil at room 
temperature on an orbital shaker.  Once labeled, any leftover unbound amine-
reactive probes were filtered out in order to eliminate erroneous protein 
quantification.  The four solutions were transferred to separate larger centrifugal 
filter tubes (Amicon Ultra – 4 Ultracel – 10k Regenerated Cellulose 10,000 
MWCO, Millipore)) and spun in a centrifuge (Marathon 21 K/R, Fisher Scientific) 
at 3000 rpm and 25°C for three sets of 1 hour time periods.  At the end of each 
period, carb-bicarb buffer was filled to the 1mL mark on the tube so that the non-
filtered material was allowed to disperse before being spun once more.  This 
maximized the amount of unbound fluorescent dye to find the filtration pores.  
After the last period, the newly labeled protein was suspended in 1mL carb-
bicarb buffer (if necessary) and stored in the -20°C freezer until use. 
3.2.3. Labeling RNase A and Trypsin 
 
Ribonuclease A (type 1-AS from bovine pancreas, 13.7kDa, Sigma) and 
trypsin (from bovine pancreas, 23.8kDa, Sigma) were used as competitors in 
rebinding experiments for lysozyme and BMP-2, respectively.  Both proteins 
make great competitors because they are of similar molecular weight and size of 
the template molecule.  RNase A and trypsin were labeled the exact same way 
as both lysozyme and BMP-2, except that they were labeled with Alexa Fluor 594 
and not 488. 
3.3. Determining Protein Concentration 
 
The BCA (bicinchoninic acid) protein assay (Pierce) was used to 
determine the concentration of protein in a solution using colorimetric detection.  
Even though a protein solution of 20mg/mL may be labeled, some content can be 
lost during transfer and filtration steps, which can slightly change the total 
concentration.  The assay begins with a simple 1:2 serial dilution of a standard 
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protein (bovine serum albumin (BSA), Pierce), making a range of dilutions each 
successively ½ the concentration of the one before it.  These dilutions therefore 
have known concentrations and are used to make a standard curve based on the 
relationship between each dilution and its corresponding absorbance value.  
Most often this correlation is best represented as a linear relationship.  Any 
absorbance values therefore that lie on this line and within the upper and lower 
limits can be interpolated to find a concentration value, meaning that the 
concentration of a protein sample with a known absorbance value can be 
accurately estimated.  The BCA assay protocol that was followed in the 
experiment was Pierce’s BCA Protein Assay Microtiter plate protocol.  Eleven 
dilutions and one blank of the known BSA protein samples as well as all of the 
unknown protein samples were transferred into a 96 well culture plate (Costar), 
which consisted of 10μL of sample and 200μL of working reagent provided in the 
BCA Protein Assay kit.  After incubation at 37°C for 30 minutes, the plate was 
placed on an absorbance reader (Dynatech MR5000 spectrophotometer), and 
the absorbance values were obtained by reading at a wavelength of 570nm.  
Using Microsoft Excel, the standard protein points were plotted (absorbance on 
the X axis and concentration on the Y), a linear regression curve was found with 
its equation, and the concentration values from the absorbance measurements of 
the unknown protein solution were determined.  These values (along with dilution 
factors) were used to come up with an average protein concentration for the 
entirely labeled and filtered protein batch. 
The BCA assay bridges the gap between a protein/peptide’s concentration 
and fluorescence properties.   When the protein was labeled with the Alexa dye, 
there was no way of relating the amount of protein to its fluorescent values alone 
since the numbers were of an arbitrary scale.  Using the BCA assay to determine 
the protein’s concentration and then matching those values to a fluorometric 
scale enabled a clear translation between fluorescence and amount of protein in 
the sample. 
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3.4. Polysiloxane Scaffold Fabrication 
 
The use of polysiloxane in the study was decided upon due to its 
effectiveness in creating imprinted scaffolds and ease of processing.  Fabrication 
of the polysiloxane scaffolds began with a two step sol-gel (part solution, part gel) 
process.  In step one, 660µL of tetraethoxysilane (TEOS) (Fluka), a cross-linking 
agent, was mixed with 165µL of 0.1M hydrochloric acid (HCl), 117.5µL of 
absolute ethanol, and 200µL of distilled water (all per one scaffold) in a 50mL 
cylindrical tube (Fisherbrand).  The vial was then placed on an orbital shaker for 
24 hours.  In step two, 165μL of γ-aminopropyltriethoxysilane (APS) (Sigma) and 
500μL of 0.1M sodium dodecyl sulfate (SDS) were placed in 18mm diameter 
plastic vials and allowed to stand for 30 minutes at room temperature.  The 
solution was then vortexed briefly to induce small bubbles while 50μL of a 
labeled protein mix was added via pipetter (Finnpipette II, Fisherbrand).  The 
amount of protein added to each scaffold depended on the type of protein to be 
imprinted and the amount of that protein available.  For lysozyme protein 
imprinting, 0.1 mg was added.  For the lysozyme C peptide imprinting, 0.05mg 
was added to the scaffolds. For BMP-2 imprinted scaffolds, 0.03mg of protein 
was added.  The bubbles created from SDS agitation give the scaffolds their 
porous structure.  Subsequently, 1140μL of the solution in step one was quickly 
added to the plastic vials and violently vortexed from 5 to 10 seconds, forming a 
gel.  Blank scaffolds were made without the addition of protein.  All samples were 
capped and aged for 24 hours then uncapped and dried at 40ºC for 48 hours.  
The aging process allows the gel to set with the embedded protein and water, 
while incubation dehydrates the gel to form a brittle scaffold. 
The scaffolds were then shaped into uniform cylinders using an Ecomet 3 
variable speed grinder-polisher with 600 grit silicon carbide papers.  Grinding 
gave the scaffolds a uniform shape and removed the shiny outer layer residue on 
the tops and bottoms that cover protein binding sites.  The final dimensions of the 
polysiloxane scaffolds were 4mm high and 9mm in diameter.  Polymer samples 
were then rinsed three times with phosphate buffered saline (PBS) pH 7.4.  A 
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pump (ROC-R 115v 4.2amp, Gast) created the vacuum with a Pasteur pipette (5 
¾”) on the end of a clear rubber hose.  Scaffolds were stored in the multi-well 
plates covered with aluminum foil until use.  The scaffold fabrication process is 
summarized in Figure 10. 
 
Figure 10.  Fabrication process and dimensions of protein imprinted polysiloxane 
scaffolds.  Illustration adopted from the thesis of Kyoungmi Lee, 2005. 
 
3.5. Characterizing Scaffold Maximum Loading Capacity 
 
Polysiloxane scaffolds loaded with labeled protein were characterized by 
how much protein could potentially rebind based on the amount available on the 
porous surface.  Washing the scaffolds ensured that no proteins were adhering 
to the surface non-specifically.  First, both blank and fully loaded protein scaffolds 
were organized separately on the flat bottom 24 well plates.  An amount of 1mL 
of a 0.4 mg/mL protease solution (Protease E, Sigma) was then added to each 
well.  The protease digested the protein to allow it and the fluorescent label to 
diffuse out of the scaffold.  In order to quantify the amount of digested protein 
coming off the scaffold, a standard protein solution was made (similar to a BCA 
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assay) and compared to the samples in the wells.  A small portion of the stock 
labeled protein obtained after filtration was transferred into a small conical tube 
and diluted 11 times using 2:1 serial dilutions in similar tubes.  The BCA assay 
previously determined the protein’s stock concentration, so each subsequent 
dilution was determined by dividing the value by one half.  Then, 25µL of the 
serial dilutions as well as the unknown samples were placed in a half area 
bottom 96 well plate, and were placed in a fluorometric plate reader (Spectra 
MAX Gemini XS).  For Alexa Fluor 350, excitation and emission wavelengths 
were 346nm and 442nm, respectively. The collected fluorescence values were 
used to create a regression curve to compare the unknown sample protein 
concentrations in Microsoft Excel.  The protein volumes were measured at 3 and 
24 hours after protease addition. 
3.6. Preferential Binding Test 
 
The maximum loading capacity value for the polysiloxane scaffolds 
provides a good estimate of the volume of protein that will be able to rebind to 
the surface.  To test preferential binding of the template on the scaffold, a 
competitor protein was used with the same size and molecular weight.  A true 
imprint will contain chemical functional groups that complement a unique protein, 
so even though the competitor molecules may bind non-specifically in the 
crevice, the template will have a better affinity and the geometry to do so. 
The maximum loading amount was converted into moles so that an equal 
number of template and competitor proteins could compete for the binding sites.  
With lysozyme or lysozyme C peptide imprinted scaffolds, the competitor was 
RNase, and likewise with BMP-2 the competitor was trypsin.  After digestion of 
the bound protein from the previous step, the scaffolds were rinsed three times 
with PBS, pH 7.4.  The empty scaffolds were then exposed to 1mL each of a 
protein-containing solution.  Three solutions were added to both imprinted and 
blank scaffolds: one containing 1mL of the maximum loading amount of template 
protein, one containing 1mL of the maximum loading amount of competitor, and 
one with 0.5mL of the template and 0.5mL of the competitor.  Each 0.5mL 
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volume corresponded to half of the maximum loading amount, creating a 
template to competitor ratio of one to one (1:1).  The protein solutions (1:0 
(template to competitor), 1:1, and 0:1 of both imprinted and competitor) were 
allowed 24 hours to bind to the imprinted and non-imprinted scaffolds.  Because 
the proteins were labeled with light sensitive fluorescent markers, the wells were 
covered with aluminum foil.  The plate was placed on an orbital shaker at room 
temperature for 24 hours. 
After 24 hours, the wells were rinsed three times with PBS.  Rinsing the 
scaffolds in this case removed all excess protein that may have been loosely 
bound to the surface.  With no solution in the wells, 1mL of 0.4 mg/mL protease 
mix was applied to each of the scaffolds.  The plate was then recovered and 
placed on the orbital shaker.  Over time, the protease digested the protein that 
had bound to the scaffold and their components flowed out of the porous 
structure.  The digestion of the proteins does not alter their ability to be detected 
by fluorometry, so the amount of protein that goes into solution represents the 
amount that had been preferentially bound.  A small sample of each well was 
taken 48 hours after the protease had been added (the same amount of time the 
template and competitor were allowed to bind).  Each sample was placed in one 
well of the 96 well, half area plate according to the position of the original wells 
the scaffolds rested in.  The plate was then read using the fluorometric plate 
reader to find fluorescent values for each sample.  Since template and competitor 
protein binding amounts were compared, both were labeled with different 
fluorescent markers.  The samples therefore were read at two different excitation 
and emission wavelengths.  Alexa Fluor 488 had excitation and emission 
wavelengths of 495nm and 519nm, respectively, while Alexa Fluor 594 had 
excitation and emission wavelengths of 590nm and 617nm, respectively.  
Fluorescent standards for both template and competitor were made using the two 
respective filtered working stock protein concentrations.  Pure stock was serial 
diluted by one half 11 times (the 12th value was blank buffer) and ran to 
determine fluorescence values.  These values in conjunction with the known 
protein concentrations allowed a linear regression curve to be made.  The 
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fluorescent values measured from the samples in the wells containing the 
released protein were then compared with the regression curve to determine 
approximate concentrations and mass values.  
3.7. Statistical Analysis 
 
A two-way analysis of variance (ANOVA) was run using the computer 
program Graphpad Prism v4.03 to determine statistical significance of the type of 
protein and ratio groups for lysozyme, BMP-2, and peptide imprinted scaffolds.  
In addition, Bonferroni post tests were done to determine interaction between the 
groups.  T-tests on the results of the protein imprinted and peptide imprinted 
scaffolds were done using Graphpad Prism.  A power analysis was run using the 
program Power and Precision release 2.1 to find the number of samples (N) 
required for obtaining a power of 0.80 for all statistically insignificant data.  Alpha 
for the power analysis was 0.05 with 2 tails.  All results are plotted as mean ± 
standard deviation (SD), unless otherwise specified. 
3.8. Cytocompatibility 
3.8.1. Preparation 
 
The in vitro study consisted of growing cells on blank polysiloxanes 
scaffolds.  Sterilization of the scaffolds involved submerging them in 70% ethanol 
(dilution of absolute ethanol, Sigma-Aldrich) in a 15mL sterile conical tube and 
centrifuging them at 1500 rpm for 5 minutes.  The scaffolds were then placed in a 
6 well plate under a sterile hood without UV light and submerged in 5mL of PBS 
for 24 hours to diffuse out any harmful residual ethanol.  The scaffolds were then 
allowed to air dry under the hood for 3 hours.  The experiment contained three 
groups: 1.) wells with cells but no scaffolds, 2.) wells with cells on scaffolds, and 
3.) wells with no cells but containing scaffolds.  C3H/10T1/2 (C3H; CCL-226, 
ATCC Rockville, MD) cells were cultured and passaged in T-75 cell culture flasks 
(Corning; Corning, NY).  An amount of 100,000 cells were seeded directly on the 
scaffolds or onto the floor of the tissue culture wells in a volume of 270µL and 
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incubated for 2 hours to allow for infiltration and attachment.  Phenol red free 
medium (Minimum Essential Medium Alpha, Gibco) with 10% heat-inactivated 
fetal bovine serum (FBS) was added to each well in 5mL aliquots.  Cell-free wells 
contained scaffolds immersed only in aMEM + 10% FBS.  Samples were then 
incubated for 1, 3, and 7 days, during which they were subjected to a 
deoxyribonucleic acid (DNA) assay to determine DNA content. 
3.8.2. Determining Deoxyribonucleic Acid Content 
 
The amount of DNA was determined using the Hoechst 33258 assay to 
test the cytocompatibility of the scaffolds.  Scaffolds that were seeded with C3H 
cells were washed with warm PBS twice, and then submerged in 1mL of high salt 
buffer (pH 7.4, containing 0.05M NaH2PO4, 2M NaCl and 2 mM EDTA).  All wells, 
including those without scaffolds and only cells, were sonicated and stored in the 
freezer for later use.  Once all samples were collected for each time period (1, 3, 
and 7 days), the lysates were centrifuged to separate disintegrated scaffold 
materials from the DNA-containing supernatant using an Eppendorf 5145 
centrifuge.  Two-fold serial dilutions of calf thymus DNA were made in the high 
salt buffer for running a standard curve to determine the unknown DNA 
concentrations in each well.  Each sample, including the two-fold standard 
amounts, was added to a 96 well plate.  An amount of 50μL of Hoechst 33258 
reagent per 200μL of DNA supernatant was added to each sample and covered 
in the dark for 10 minutes.  Fluorescence was measured at 356nm excitation and 
458nm emission using a fluorometric plate reader. 
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4. Results 
4.1. Fabrication of Scaffolds 
The polysiloxane scaffolds created in the present study were cylinders 
with dimensions of 4mm in height and 9mm in diameter.  The scaffolds had a 
bright white color, and after hardening became very brittle and porous (Figure 
11).  In a previous experiment [54], the average pore size for the scaffolds was 
found to be 6.19µm, while the average porosity was 43%.  Throughout most of 
the experiments, the scaffolds retained shape and porosity except for a few 
instances where degradation occurred during long immersion periods (greater 
than 120 hours). 
 
 
Figure 11.  Dimensions of the fabricated porous polysiloxane scaffolds. 
 
During polymerization, 50µL of protein was inserted in the vial just before 
step 1 and 2 solutions were mixed together.  As the mix was vortexed, the liquid 
within a matter of seconds became gelatinous.  During that short period, 
however, the liquid splashed around and separated from the bulk which created 
random spots on the sides of the tube.  As the polymer aged and dried in the 
oven, much of the polymer remained as a residue on the sides and on the bottom 
of the container.  When removed from the tube, the shape of the polymer on the 
top was not perfectly flat due to the vortexing step.  The side surface and bottom 
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however were circular and flat, respectively.  Grinding of the scaffold, therefore, 
was necessary to reshape the scaffolds into uniform cylinders in addition to 
removing the glassy surface on the tops and bottoms. 
To compensate for such large protein losses and therefore reduced 
number of imprints, the scaffold protein density was increased.  This was done 
by adding a higher mass of protein and reducing the polymer volume to two-
thirds of the original.  Polymerization was achieved using two-thirds of the 
original volume of each component.  For instance, only 760µL (originally 1140µL) 
of step one was added to step two, which itself consisted of 110µL APS and 
333µL of SDS (originally 165µL of APS and 333µL of SDS).  The result was a 
scaffold approximately two thirds the size of the original but with the same 
characteristics.  The dried polymer residue on the sides of the tube was still 
present, and after grinding, the dimensions were 3.35mm in height and 8.4mm in 
diameter (compared to the original 4mm by 9mm). 
4.2. Protein Maximum Loading Capacity 
4.2.1. Comparison of Protein to Peptide 
 
After the polysiloxane scaffolds embedded with protein were fabricated 
and shaped into cylinders, they were exposed to 1mL of a 0.4mg/mL protease 
mix.  The protease digested all of the protein it came in contact with, suggesting 
the protein on the direct surface within the porous structure was affected.  When 
the protein was broken down, its complementary chemical and spatial 
arrangement was left exposed.  Therefore, a direct correlation was made 
between protein digested from the scaffold and the amount of imprinting sites 
available for preferential rebinding of the same protein.  Amounts of digested 
lysozyme protein were determined using a fluorometric reader for 3, 24, 48, and 
96 hours after the addition of the enzyme.  It was found that beyond 24 hours the 
rate of protein unloading from the scaffold was relatively small and therefore not 
considered in the analysis (Figure 12).  This was used as a guide for the 
proceeding maximum unloading experiments which involved the release of 
lysozyme protein and lysozyme C peptide. 
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Figure 12.  Release rate of protein from scaffolds as a function of time following 
protease addition.  The level of protein release slowed after 24 hours (mean ± 
SD of 10.57 ± 1.36, n=7). 
 
Figure 13 shows the maximum loading capacity for the lysozyme 
imprinted scaffolds, and Figure 14 shows the capacity values for the lysozyme C 
peptide imprinted scaffolds.  In this instance, 0.1mg of lysozyme protein and 
0.05mg of peptide was added to the polymerization mix.  Because a larger 
amount of protein was used to make the lysozyme imprinted scaffolds, a greater 
amount was recorded leaving the protein scaffold than leaving the peptide 
scaffold.  The protein amounts recorded at 3 hours and 24 hours after protease 
addition were found to be statistically different (p<0.001) for both protein and 
peptide imprinted scaffold groups.  In addition, at 3 and 24 hours, values were 
statistically different between both protein and peptide imprinted groups 
(p<0.001).  Again, no data past 24 hours was recorded since the amount 
released topped off around this time. 
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Figure 13.  The amount of protein released (mean ± SD) from lysozyme 
imprinted scaffolds via digestion with 0.4mg/mL of protease after 3 and 24 hours. 
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Figure 14.  The amount of peptide released (mean ± SD) from lysozyme C 
peptide imprinted scaffolds via digestion with 0.4mg/mL of protease after 3 and 
24 hours. 
 
In Table 1, the mass percentage of the amount of initial added 
protein/peptide that was released from the scaffolds is shown.  A larger amount 
of protein was removed from the protein imprinted scaffold from the peptide 
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imprinted scaffold (67.93μg compared to 21.76μg), resulting in a higher 
percentage for the former.  
 
Table 1.  Results of the maximum loading capacity for protein and peptide 
imprinted scaffolds (mean ± SD). 
  Lysozyme Peptide 
Number of Scaffolds (n) 4 12 
Amount of Protein Added to 
Polymerization Mix (µg) 100.00 50.00 
Average Amount of Protein 
Released from Scaffold (µg) 
(24 hr) 
67.65 ± 14.38 20.71 ± 2.18 
Percent Protein that forms 
Imprints 67.65 ± 14.38 41.40 ± 1.45 
 
4.2.2. Variation in Volume of Scaffold 
 
With the idea of increasing the number of binding sites while minimizing 
protein losses from fabrication, the volume of polymerization mix was reduced to 
two-thirds normal.  Adding a higher amount of protein to a smaller volume of 
polymer could increase the density and distribution of potential binding sites 
throughout the scaffold.  Figure 15 shows the maximum loading capacity for 
scaffolds imprinted with lysozyme C peptide with the normal volume, and Figure 
16 shows the loading capacity for the two-thirds volume scaffolds imprinted with 
the peptide.  An amount of 0.0174mg of peptide was loaded into the normal 
volume scaffolds made, while 0.026mg of peptide was loaded into the two-thirds 
volume scaffolds.  Also, the normal scaffolds were polymerized in 18mm 
diameter tubes while the two-thirds volume scaffolds were polymerized in 15mm 
glass tubes.  The smaller diameter tube was used to enhance the shrinkage of 
the dimensions of the partial volume scaffolds during polymerization. 
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Figure 15.  The amount of peptide released (mean ± SD) from full volume 
lysozyme C peptide imprinted scaffolds via digestion with 0.4mg/mL of protease 
after 3 and 24 hours. 
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Figure 16.  The amount of peptide released (mean ± SD) from partial volume 
lysozyme C peptide imprinted scaffolds via digestion with 0.4mg/mL of protease 
after 3 and 24 hours. 
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Table 2 shows the amounts and percentages of the released peptide after 
24 hours.  It appears that an increase in the initial peptide amount and a 
decrease in polymerization mix volume resulted in no quantifiable difference 
between the release of partial and full volume scaffold peptides. The released 
protein amount between 3 hours and 24 hours was found to be statistically 
different (p<0.05) after protease addition for both full and partial volume scaffold 
groups.  However, the values at 3 hours between the full and partial groups were 
not significantly different (p>0.05), likewise with the values at 24 hours.  While the 
amount of peptide digested by the protease remained the same for both groups, 
the percentage of peptide was higher for the full volume scaffolds than for the 
partial volume scaffolds. 
 
Table 2.  Results of the maximum loading test for both full and partial volume 
peptide imprinted scaffolds (mean ± SD). 
  Full Volume Partial (2/3) Volume 
Number of Scaffolds (n) 9 12 
Volume of Scaffold 
(mm³) 1017.9 742.6 
Amount of Peptide 
Added to 
Polymerization Mix (μg) 
17.40 26.00 
Average Amount of 
Peptide Released from 
Scaffold (μg) (24hr) 
6.99 ± 0.95 6.88 ± 1.25 
Percent Peptide that 
forms Imprints (%) 
(24hr) 
40.16 ± 5.49 26.45 ± 4.81 
 
4.2.3. BMP-2 
 
BMP-2 protein was also used to make imprints in the polysiloxane 
scaffolds.  After digesting in 0.4mg/mL protease, the amount of protein released 
from the scaffolds was measured using a fluorometric plate reader at three and 
twenty four hours.  Figure 17 shows the amount of BMP-2 that was embedded in 
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the surface of the scaffold, digested, and released via the protease. The amount 
of BMP-2 added to the polymerization mix was 0.025mg.  The amount of protein 
determined was used to approximate the amount of molecules that can 
potentially rebind to the newly made imprints.  Table 3 shows the amount of 
BMP-2 released after 24 hours and the percentage of total protein digested out of 
the scaffold and used to make imprints.  The protein amount for 3 hours and 24 
hours was found statistically different (p<0.001) after protease addition for the 
BMP-2 imprinted scaffold group. 
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Figure 17.  The amount of protein released (mean ± SD) from BMP-2 imprinted 
scaffolds via digestion with 0.4mg/mL of protease after 3 and 24 hours. 
 
 
Table 3.  Results of the maximum loading capacity for BMP-2 imprinted 
scaffolds. 
  BMP-2 
Number of Scaffolds (n) 15 
Amount of Protein Added to 
Polymerization Mix (μg) 30.00 
Average Amount of Protein 
Released from Scaffold (μg) 
(24hr) 
22.95 ± 1.70 
Percent of Protein that forms 
Imprints 74.13 ± 5.66 
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4.3. Protein Preferential Binding 
4.3.1. Lysozyme Imprinted Scaffolds 
 
To test the principles of molecular imprinting with proteins and develop a 
standard for comparison, lysozyme was imprinted onto polysiloxane scaffolds 
and tested for preferential binding. At 24 hours, the amount of released protein 
was approximately 67µg (see Table 1).  This amount corresponded to 
approximately 4.5 x 10-9 moles of lysozyme protein molecules.  Assuming that 
this number equaled the number of imprints on the scaffolds, approximately 62µg 
of RNase A and 67µg of lysozyme were added to each well with a 0:1 and 1:0 
ratio, respectively.  For the 1:1 ratio wells, 31µg of RNase A and 33.5µg of 
lysozyme were added.  The protein was allowed 24 hours to bind to the scaffolds 
and another 24 hours to digest via protease.  Figure 18 shows the average 
difference in the actual amount of protein between the imprinted and blank 
scaffold types.  Figure 19 shows the average difference in the imprinted and 
blank scaffold types in terms of percent bound. 
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Figure 18.  Results of the preferential binding (mean ± SD) on lysozyme 
imprinted scaffolds based on amount of protein. 
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Figure 19.  Results of the preferential binding (mean ± SD) on lysozyme 
imprinted scaffolds based on the percentage of protein. 
 
These figures show that there was more binding of the lysozyme protein to 
the imprinted scaffolds than the binding of RNase A under both a competitive 
(p<0.01 for amount and p<0.001 for %) and noncompetitive environment (a ratio 
of 1:0 and 0:1) (p<0.001 for amount and %).  Figure 18 shows that when an 
equal number of template and competitor protein molecules (1:1 ratio) were 
added to wells containing the scaffolds, more than 4:1 of lysozyme to RNase 
preferentially bound the polymer (p<0.01). 
Table 4 summarizes the amounts and percentages of lysozyme and 
RNase A that bound to the imprinted and blank scaffolds.  Since a certain portion 
of protein bound the blank scaffold non-specifically, this amount was subtracted 
from the imprinted scaffold data to isolate only the protein that adhered to the 
scaffold specifically via protein imprinting.  Under competition (1:1 ratio), 
lysozyme bound about 5.1 ± 0.03% (mean ± SD) of the original amount 
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deposited in the wells due to protein imprinting, while RNase A bound only 1.32 ± 
0.23% of the original. 
 
Table 4.  Summary of the preferential binding tests for lysozyme protein 
imprinted scaffolds (mean ± SD). 
Average Protein Bound to Protein Imprinted Polysiloxane Scaffolds  (n=3 for each ratio) 
  Lysozyme RNase A 
Ratio 1:0 1:1 0:1 1:0 1:1 0:1 
Imprinted Scaffolds       
Amount Added (µg) 67.00 33.50 0 0 31.00 62.00 
Amount Rebound (µg) 8.46 ± 0.00 3.25 ± 0.00 0 0 1.32 ± 0.00 2.78 ± 0.00 
        
Blank Scaffolds       
Amount Added (µg) 67.00 33.50 0 0 31.00 62.00 
Amount Rebound (µg) 3.01 ± 0.00 1.54 ± 0.00 0 0 0.91 ± 0.00 2.03 ± 0.00 
        
Difference (Imprinted 
minus Blank)       
Amount Rebound (µg) 5.45 ± 0.66 1.71 ± 0.01 0 0 0.41 ± 0.07 0.75 ± 0.04 
Percent Rebound (%) 8.13 ± 0.99 5.10 ± 0.03 0 0 1.32 ± 0.23 1.21 ± 0.06 
 
4.3.2. Lysozyme C Peptide Imprinted Scaffolds 
 
Many polysiloxane scaffolds were imprinted with lysozyme C peptide, a 
small amino acid sequence found on the surface of the lysozyme protein.  It is 
desired that the peptide imprint bind the protein to the same degree that it is 
bound using the imprint of the entire structure.  In a separate experiment it was 
found that the amount of peptide released from the scaffolds in 24 hours was 
7.4µg (note: this is not the same batch of scaffolds from which the value of 21µg 
was obtained (Table 1)).  The number of moles of lysozyme C peptide in 7.4µg 
was 4.22 x 10-9, suggesting that potentially the same number of lysozyme 
proteins can bind the surface where the peptide imprints were created.  An 
amount of 4.22 x 10-9 moles corresponded to 0.061mg of lysozyme (template) 
and 0.058mg of RNase A (competitor).  In this circumstance the template and 
competitor were the same as with the lysozyme imprinted scaffolds.  As before, 
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the 24 well plate contained imprinted and blank (non-imprinted) scaffolds with 
groups representing a template to competitor ratio of 1:0, 1:1, and 0:1.  Figure 20 
and Figure 21 show the protein amounts and percentages, respectively, where 
the blank has been subtracted from the imprinted scaffolds.  Interestingly, the 
standard deviation error bars are so large that the data could suggest there is no 
difference in preferential binding for the lysozyme.  There appears to be a 
difference between binding under noncompetitive conditions (p<0.05 for amount 
and p>0.05 for %), but during competition the two proteins seemed to have 
bound the same amount.  After statistical analysis, this indeed was found to be 
the case (p>0.05 for amount and %). 
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Figure 20.  Results of the preferential binding (mean ± SD) on peptide imprinted 
scaffolds based on the amount of protein. 
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Figure 21.  Results of the preferential binding (mean ± SD) on peptide imprinted 
scaffolds based on the percentage of protein. 
 
Table 5 summarizes the percentages and amounts of lysozyme and 
RNase A that bound to the peptide imprinted and blank scaffolds.  Since a 
certain portion of protein bound to the blank scaffolds non-specifically, this 
amount was subtracted from the imprinted scaffold data to isolate the protein that 
adhered to the scaffold specifically via protein imprinting.  Under competition (1:1 
ratio), lysozyme bound about 1.85 ± 9.47% (mean ± SD) of the original amount 
deposited in the wells due to protein imprinting while RNase A bound 0.83 
±1.39% of the original.  Unexpectedly, the standard deviations for the peptide 
imprinted data are unusually high.  A power analysis was run to determine the 
appropriate sample size of imprinted scaffolds needed for a significant difference 
between template and competitor binding on the 1:1 level.  For n=11 and an 
approximate mean and SD of 0.55 ± 2.95µg for lysozyme and 0.45 ± 0.79µg for 
RNase A, a sample size of 7,322 would be needed to produce a power of 0.80.  
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Table 5.  Results for the preferential binding tests (mean ± SD) of protein 
adsorption on lysozyme C peptide imprinted polysiloxane scaffolds. 
Average Protein Bound to Peptide Imprinted Polysiloxane Scaffolds (n=11 for each ratio) 
  Lysozyme RNase 
Peptide Imprinted 
Scaffolds 1:0 1:1 0:1 1:0 1:1 0:1 
Amount Added (µg) 61.00 30.50 0 0 29.00 58.00 
Amount Rebound (µg) 26.32 ± 4.81 12.28 ± 4.00 0 0 9.17 ± 1.28 21.03 ± 2.56 
              
Blank Scaffolds             
Amount Added (µg) 61.00 30.50 0 0 29.00 58.00 
Amount Rebound (µg) 21.16 ± 8.50 11.74 ± 3.68 0 0 8.72 ± 1.63 20.36 ± 2.40 
              
Difference (Peptide 
Imprinted minus Blank)             
Amount Rebound (µg) 5.15 ± 6.88 0.55 ± 2.95 0 0 0.45 ± 0.79 0.67 ± 1.98 
Percent Rebound (%) 8.59 ± 11.54 1.85 ± 9.47 0 0 0.83 ± 1.40 2.31 ± 6.87 
 
4.3.3. Comparison of Protein to Peptide Imprinted Scaffolds 
 
In addition to looking at the groups of protein imprinted scaffolds and 
peptide imprinted scaffolds individually, a comparison was made to identify if one 
type of scaffold preferentially binds a different amount of protein than the other.  
Statistical analysis was used to compare significant differences in means 
between the two scaffold types under the non-competitive case (1:0 and 0:1) and 
competitive case (1:1).  In the 1:0 case, no statistical difference in lysozyme 
binding between protein and peptide imprinted scaffolds was determined.  In the 
0:1 ratio case, it was determined that no statistical difference in RNase A binding 
between the two scaffold types existed.  In the 1:1 ratio case for lysozyme 
binding, no statistical difference between protein and peptide imprinted scaffolds 
was found.  Also, for RNase A binding in the 1:1 ratio case, no statistical 
difference between protein and peptide imprinted scaffolds had occurred.  In 
other words, there was no difference in the amount of protein that binds the 
protein imprinted scaffolds and peptide imprinted scaffolds in all cases (p>0.05). 
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In each comparison of the scaffold types, a power analysis was used to 
determine the number of samples required to obtain a power of 0.80.  Table 6 
below summarizes the results of each statistical comparison with the required 
number of samples for the desired power.  In comparison 1 and 2, both lysozyme 
and RNase A binding are compared under noncompetitive conditions between 
peptide and protein imprinted scaffolds.  In order for a significant difference in 
binding to be observed for lysozyme and RNase A, 4,130 scaffolds and 4,881 
scaffolds need to be fabricated, respectively.  Under competition, 3,087 scaffolds 
are necessary to see a difference in RNase A binding between the two types of 
scaffolds, while only 52 scaffolds are necessary for lysozyme. 
 
Table 6.  Summary of the statistical comparison of protein that bound to protein 
and peptide imprinted scaffolds. 
  Comparison 1 Comparison 2 Comparison 3 Comparison 4 
 Type of protein Lysozyme RNase A Lysozyme RNase A 
 Ratio (Template vs Competitor) 1:0 0:1 1:1 1:1 
Mean (µg) 5.45 0.75 1.71 0.41 
Protein 
Imprinted Standard 
Deviation (µg) 0.07 0.04 0.01 0.07 
Mean (µg) 5.15 0.67 0.55 0.45 
Peptide 
Imprinted Standard 
Deviation (µg) 6.88 1.98 2.95 0.79 
 p value p>0.05 p>0.05 p>0.05 p>0.05 
 Significant Difference? No No No No 
 Desired Power 0.8 0.8 0.8 0.8 
 N required for desired power 4,130 4,811 52 3,087 
 
4.3.4. BMP-2 Imprinted Scaffolds 
 
BMP-2 is a key player in the differentiation of osteogenic bone cells and 
bone formation.  BMP-2 was imprinted into polysiloxane scaffolds because of its 
promising potential for bone regeneration and wound healing.  The BMP-2 
imprinted scaffolds were exposed to protease in the same manner as the 
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lysozyme scaffolds for 24 hours, and a release amount of 23µg was measured 
using a fluorometric plate reader.  The amount of template (BMP-2) and 
competitor (trypsin) added to the 1:0 and 0:1 protein mixes, respectively, were 
both 23µg.  Since both trypsin and BMP-2 have a very similar size (MW), an 
equal amount of both were placed in the wells.  For the 1:1 ratio wells, 0.5mL of 
both 23µg protein mixes (11.5µg each) were placed in the wells.  The results of 
the amount of protein released from the BMP-2 imprinted scaffolds are shown in 
Figure 22 for the amount of protein bound and Figure 23 for the percentage 
bound.  Both figures show a noticeable binding of BMP-2 to scaffolds at the 1:0 
ratio, as well as a very small but equal amount on scaffolds with a 1:1 ratio, and a 
negative value for the 0:1 ratio.  The standard deviation bars are quite large for 
all scaffold types.  Under noncompetitive conditions, a difference in protein 
binding can be seen (p<0.001 for amount and percent bound), which is enhanced 
by the negative value for amount of competitor bound.  Under the competitive 
case, the data suggest that there was no preferential binding of BMP-2 on 
imprinted scaffolds compared to blank, while statistical analysis shows this to be 
true (p>0.05 for amount and %). 
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Figure 22.  Results of the preferential binding (mean ± SD) on BMP-2 imprinted 
scaffolds based on the amount of protein. 
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Figure 23.  Results of the preferential binding (mean ± SD) on BMP-2 imprinted 
scaffolds based on the percentage of protein. 
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Table 7 summarizes the percentages and amounts of BMP-2 and trypsin 
that bound to the BMP-2 imprinted and blank scaffolds.  The results presented in 
the table as well as the figures pertaining to BMP-2 are similar to the experiments 
completed with the lysozyme protein and peptide in that the standard deviations 
are extremely high.  Under competition, the BMP-2 imprinted scaffolds bound a 
very small 0.65 ± 4.55% of the original amount deposited in the wells due to 
protein imprinting while trypsin bound 0.49 ± 1.77% of the original.  A power 
analysis was run to determine the appropriate sample size of imprinted scaffolds 
needed for a significant difference between template and competitor binding on 
the 1:1 level.  For n=13 and an approximate mean and SD of 0.08± 0.52µg for 
lysozyme and 0.11± 0.41µg for RNase A, a sample size of 3,826 would be 
needed to produce a power of 0.80. 
 
Table 7.  Results for the preferential binding tests of protein adsorption on BMP-2 
imprinted polysiloxane scaffolds. 
Average Protein Bound to BMP-2 Imprinted Polysiloxane Scaffolds (n=13 for all ratios) 
  BMP-2 Trypsin 
BMP-2 Imprinted Scaffolds 1:0 1:1 0:1 1:0 1:1 0:1 
Amount Added (µg) 23.00 11.50 0 0 23.00 11.50 
Amount Rebound (µg) 12.25 ± 6.33 5.16 ± 3.92 0 0 1.59 ± 0.30 3.00 ± 0.42 
              
Blank Scaffolds             
Amount Added (µg) 23.00 11.50 0 0 23.00 11.50 
Amount Rebound (µg) 10.47 ± 7.58 5.10 ± 4.01 0 0 1.48 ± 0.28 3.47 ± 1.33 
              
Difference BMP2 
(Imprinted minus Blank)             
Amount Rebound (µg) 2.32 ± 1.52 0.08 ± 0.52 0 0 0.11 ± 0.41 -0.53 ± 0.94 
Percent Rebound (%) 10.09 ± 6.62 0.65 ± 4.55 0 0 0.49 ± 1.77 -4.60 ± 8.16 
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4.4.  Cytocompatibility 
4.4.1. Preparation 
Non-imprinted polysiloxane scaffolds were investigated for their ability to 
sustain cell viability for one week.  While seeding the polymer scaffolds, some of 
the medium containing the cells spilled over the top surface edge and onto the 
bottom of the tissue culture plastic well.  The condition of these cells was used to 
observe the effects caused by the scaffold in its immediate vicinity (10-20 µm).  
On days 4 through 7, spread cells were seen in small groups where they had first 
settled on day 1 after seeding.  These cells, however, were not grown on the 
scaffolds, and therefore were not included in the proceeding results. 
4.4.2. C3H Cell Growth 
The ability for cells to grow on the blank polysiloxanes scaffolds was 
determined by quantifying the amount of DNA present at 1, 3, and 7 days.  The 
number of cells present is related to the quantity of DNA determined using the 
DNA assay.  The results of the DNA analysis are shown in Figure 24 after an 
initial amount of 100,000 cells was seeded on the surface of either the tissue 
culture plastic or the porous polymer scaffold.  Throughout the entire week of 
incubation, the amount of DNA present on tissue culture plastic at the bottom of 
the plate exceeded the amount grown on the polymer scaffolds (p<0.05).  The 
amount grew after the first three days and remained a constant value of about 
1.2μg for the next four days.  Cells present on the scaffolds however lacked the 
ability to proliferate.  The DNA content started at a low amount after initial 
seeding of the C3H cells and remained at an approximate value of 0.2μg 
throughout the entire experimental timeframe.  During day 3 and 7, there 
appeared to be a slight increase of cell growth up to 0.4μg of DNA.  It was found 
however that there was no statistical difference between the amount of DNA 
measured on day 3 compared to day 7 (p>0.05). 
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Figure 24.  DNA contents from C3H cells cultured on blank scaffolds (n=3) and 
on tissue culture plastic after periods of 1, 3, and 7 days. 
 
5. Discussion 
 
Due to their effectiveness in specific recognition of biomolecules, 
molecularly imprinted polymers are being developed for many chemical and 
medical applications, including solid phase extraction and chromatography, 
biosensors, and signaling polymers [55].  MIPs also have potential for use in 
tissue engineering, a discipline that brings together biology and the science of 
materials.  For example, substrates that selectively bind particular proteins in a 
physiological environment can facilitate desired cell and tissue responses, which 
are critically dependent on the type and nature of adsorbed biomolecules [34]. 
5.1. Fabrication of Scaffolds 
The process of creating scaffolds for the investigation of molecular 
imprinting protein is not yet an exact science.  Several challenges have been 
identified concerning imprinting protein into molecularly imprinted polymers, such 
as problems with the high flexibility of the conformation [56] and complexity of 
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surface structures inducing poor accessibility of the binding sites, low binding 
capacity, and large non-specific binding [4].  Solutions to creating efficient 
scaffolds lie within both the protein that is being imprinted and the material that 
constitutes the imprint.  For instance, Shi et al. investigated imprinting protein 
using radio frequency glow-discharge plasma deposition to form polymeric thin 
films around proteins coated with disaccharide molecules with the intent of 
improving binding efficiency.  The disaccharides attached to the polymer film and 
created cavities that exhibited selective recognition for many template molecules 
[57]. 
The properties of a protein, both physical and chemical, make the 
fabrication process difficult.  The conformation of a protein is quite flexible, and 
while an imprint of the protein is made in one position, it may be difficult for 
another protein of the same type to perfectly fit that original shape [4].  In 
addition, the three dimensional configuration of the functional groups within a 
protein gives rise to a challenging situation for another to rebind with the same 
orientation when coming in contact with the surface of the imprint.  The 
orientation, for instance, of the peptide imprint might not allow binding of the 
whole protein because it does not precisely match its conformation (Figure 8).  In 
many cases, the effectiveness of the molecular recognition depend on both the 
matrix functional monomers and cross-linking monomers [48]. 
Because of its potential for greater stability, silica was used for the present 
studies [54].  During polycondensation to form the polysiloxane network, amino 
groups on the functional monomer aminopropyltriethoxysilane (APS) are able to 
interact with the template (protein or peptide).  The tetraethoxysilane (TEOS) 
molecules then cross-linked the monomers and locked the template into its 
position in the silica.  The sol-gel processing to fabricate scaffolds was simple, 
but to make macroporous (foamed) scaffolds, samples were made one at a time, 
which led to variability between scaffolds, as reflected in some of the results 
presented.  Splattering of the material as it mixes creates a loss of polymer 
volume and protein that could contribute to more imprints.  Also, grinding is done 
manually, which leads to scaffolds of various shapes, volumes, and surface 
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areas, and hence inconsistent data markings. One aspect of the grinding step 
that has not yet been explored is the effect of heat generated from friction.  It 
may be possible that this energy not only disrupts the surface of the polymer but 
the conformation of the protein imprinted onto the scaffold as well.  If this were 
the case, the release profile of the protein during the maximum loading test may 
be affected since the damage to the protein via grinding may inhibit fluorescence 
intensity. 
A side experiment conducted in the study was done to test scaffold 
volume variability and its effects on protein loading capacity.  This involved the 
fabrication of two groups of scaffolds, one with a normal volume of 
polymerization mix and another with two-thirds the normal volume.  The 
noticeable difference in structure and shape of the partial volume scaffolds after 
grinding can be explained by how they were made.  Unlike the normal scaffolds, 
the partial volume scaffolds were made in glass vials (plastic vials were used for 
normal fabrication).  The difference in tube material could have an interaction 
with the polymer itself, leading to an increase in residual mix left on the sides of 
the cylinder.  A smaller bulk polymerization mix volume will have a greater 
tendency to splash around the tube instead of staying stable while mixing.  
Another potential cause for the difference in scaffold structure between the two 
was in the grinding step.  Grinding the scaffolds serves as a means to make each 
a similar shape and to remove the glassy layer that interferes with protein 
imprinting.  The smaller scaffolds are harder to hold, therefore harder to shape 
and are structurally less stable since less material is present.  This creates a 
larger variability in the physical characteristics of the partial volume scaffolds, 
which may lead to greater experimental variations in data. 
5.2. Protein Maximum Loading Capacity 
 
Maximum loading capacity experiments were useful in that they 
determined the amount of surface protein or peptide that remained on the 
scaffolds and therefore the amount of potential imprints available for specific 
rebinding.  Due to the porous nature of the scaffolds, the digested protein was 
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released from the surface at an exponential rate with a plateau close to 24 hours.  
Protein or peptide exposed on the outer portion of the scaffold was digested and 
released quickly, while those within the pores took longer to diffuse outward. 
The results for the maximum loading capacity for the lysozyme and 
lysozyme C peptide imprinted scaffolds are shown in Table 1.  A larger mass 
percentage (about 26%) of lysozyme protein was released from the scaffolds 
compared to the peptide-imprinted samples.  Reasons for the release behavior 
for each type of scaffold could depend on the size of the molecules as well as 
interactions between them and the surrounding polymer.  More peptide could be 
embedded in the polymer beyond the reach of the protease so that less is able to 
release from the surface (due to sol-gel processing).  Having such a large 
molecule digest the small peptide would prove to be difficult since the imprint is 
so small.  The larger, entire protein molecule despite the smaller quantity would 
be able to expose itself to a higher amount of surface area where it would be 
vulnerable to protease digestion (Figure 8). 
Surprisingly, results showed that for the partial volume polymerization mix 
experiment, the same amount of lysozyme C peptide was released from both 
normal and two-thirds volume scaffolds.  This suggests that an increase in 
surface density, or a higher ratio of mass per scaffold volume (volume density), 
will not change the amount of released peptide because of a saturation in the 
amount that can occupy space within the polymer.  One would expect that the 
increase in density would allow more peptide molecules to be exposed on the 
surface since more are available per unit volume.  However, this was not the 
case.  Much of the peptide added in the polymerization mix was embedded into 
the bulk of the polymer and not surface accessible for digestion and creating 
imprints.  This capping or saturation of peptide in the scaffolds may be explained 
by the space the molecules occupy around the pores.  Vigorous mixing of the 
polymerization mix with the vortex device creates many tiny bubbles due to the 
presence of SDS.  Once there is a layer of peptide around the pore, the affinity 
for another peptide to bind the surface is very small.  This prevents all of the 
peptide from polymerizing with the polymer at the surface, so any extra is 
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embedded into the bulk solid.  As the peptide is digested, only those on the 
surface are released and quantitatively measured while the large amount of 
peptide embedded in the bulk is not.  This may be the reason why decreasing the 
volume and increasing the peptide amount does not change the amount released 
from the surface.  In one study, Chipot and Pohorille determined that the 
behavior of peptides on membrane interfaces depended on hydrophobic effects, 
intramolecular hydrogen bonding, and interactions with interfacial electrical fields 
[58].  In other words, the structure of the peptide may be influenced by the 
chemistry of the membrane that it is exposed to, which might explain the 
peptide’s affinity to certain air-gel surfaces and bulk polymer interfaces, each with 
their own surface chemistry characteristics [58]. 
5.3. Protein Preferential Binding 
5.3.1. Lysozyme Protein vs. Lysozyme C Peptide Imprinted Scaffolds 
 
The results from the lysozyme-imprinted scaffold experiments showed 
excellent preferential binding.  The template protein bound significantly more to 
the polymer scaffolds than the competitor on both the individual exposure level 
(1:0 and 0:1) and in the 1:1 lysozyme to RNase A competitive level.  The 
experiments showed that successful preferential binding can be achieved by 
using proteins as imprints to rebind the template molecule.  The results for the 
peptide-imprinted scaffolds, however, did not share the same statistical 
soundness.  Bonferroni post test determined that there was a significant 
difference in the binding of lysozyme compared to RNase A for the 1:0 and 0:1 
ratio but not for the competitive 1:1 ratio case. Similarly, for the total percent of 
bound protein, there was not a statistical difference of preferential binding in any 
case. In other words, the data suggest that using peptides as imprints to 
preferentially bind the protein may not be as effective as when imprinting the 
entire molecule. 
The extremely large variability found in Figure 20 and Figure 21 
challenges the efficiency of peptide imprinted polymers to allow for preferential 
protein binding.  The trends, however, in each of these graphs are very similar to 
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that of the lysozyme protein imprinting data, as are the average values for each 
ratio.  This suggests that preferential binding could still be accomplished if the 
variability was reduced. Note how in Table 5 that the amount of protein that binds 
to the blank scaffolds is relatively similar to the amount that binds the imprinted 
scaffolds.  Subtracting the blank values would therefore decrease the amount of 
peptide that binds due to the influence of imprinting, but keep the standard 
deviations approximately the same.   
Another source of error is believed to come from variability in the structure 
of the scaffolds.  When the scaffolds are fabricated, grinding of the scaffolds is 
done on an individual basis.  This creates scaffolds of different dimensions and 
shapes, ultimately affecting the internal structure of the molecular imprints and 
accessibility of the binding sites.  The variation in the scaffold structure produces 
different characteristics for each scaffold, and therefore induces a wide variation 
in the results.  These variations are responsible for the statistical insignificance 
determined in the ANOVA and Bonferroni post tests for peptide imprinted 
scaffolds. 
In the present study, template release and binding occurred through a 
non-covalent mechanism, which utilized hydrogen bonding, Van der Waals 
forces, ionic bonds and hydrophobic interactions with protein recognition cavities.  
The protein was imprinted into an inorganic polymer consisting of a siloxane 
bonded network.  Solutions to finding more efficient protein imprinting have been 
explored by altering the template molecule and the structure of the polymer in 
which it’s imprinted.  For example, in a study done by Shiomi et al., a new 
molecular imprinting technique using covalently immobilized hemoglobin (Hb) 
recognition cavities on silica was explored [56].  Instead of TEOS and APS as 
polymer components, organic 3-aminopropyltrimethoxysilane (APTMS), and 
trimethoxypropylsilane (TMPS) were used.  Polymerization took place on a 
surface with covalently immobilized hemoglobin using imine bonds.  Imprints 
were then created by the release of the protein via oxalic acid, instead of the 
protease used in the current study to release the lysozyme and BMP-2.  The 
hemoglobin-imprinted silica using covalently immobilized Hb as a template 
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proved to be better than using silica with free Hb regarding selective re-
adsorption as compared with other non-template proteins [56]. 
The amount of protein preferentially bound to the scaffolds was compared 
to ascertain whether or not imprinting the polymers with lysozyme C peptide was 
just as effective as imprinting with lysozyme protein.  It was hypothesized that 
specific binding of the protein could be achieved by imprinting only a small 
peptide section of the  molecule, similar to binding an antigen to an antibody 
utilizing only the epitope region.  The t tests showed that compared to each 
other, the peptide imprinted scaffolds did not significantly bind a different amount 
of lysozyme than the protein imprinted scaffolds.  Amongst themselves, trends of 
preferential binding could be seen, but between the two types of scaffolds, no 
difference was observed. 
The power analysis determined that for a significant difference in binding 
of lysozyme to both types of imprinted scaffolds to be seen under competition 
(1:1 ratio), a sample size of 52 would be necessary.  In other words, using the 
same fabrication methods, there is an 80% chance of finding a significant 
difference with 52 scaffolds.  This number is extremely low compared to the 
values determined for the noncompetitive cases and the binding of RNase A 
under competition.  This observation suggests that binding of the template 
protein under a competitive condition was more distinguished than in the solo 
case.  Lysozyme was able to more consistently bind the imprint when it was 
under competition with RNase A.  This interesting property may be explicable by 
exploring the difference in behavior of the protein and peptide imprinted 
scaffolds.  When a biomaterial enters the body, a series of proteins adsorb and 
release from the surface in sequential order based on their binding affinity 
towards the material [26].  Perhaps the binding behavior in this case may be 
understood in this new light.  Under competition, binding of the RNase A may first 
take place.  Since the template has a larger affinity for the imprint, the competitor 
is released and replaced by lysozyme.  The kinetics involved in this phenomenon 
may be unique for each type of imprinted scaffolds, making the two binding 
behaviors more distinguishable.  This would create the possibility of both protein 
54 
and peptide imprinted scaffolds having a significantly different amount of 
template molecule bind the surface. 
Successful rebinding of peptides using the epitope approach was seen, 
however, in a study performed by Rachkova and Minourab involving oxytocin-
related peptides in aqueous media [59].  Instead of using inorganic polymer 
components for scaffolds, methacrylic acid (MAA) was used as a functional 
monomer and ethylene glycol dimethylacrylate (EGDMA) was used as a cross-
linker.  The lysozyme C peptide was chosen for the present study because of its 
position on the lysozyme protein for surface recognition.  Rachkova and 
Minourab utilized the hormone oxytocin because its tail end C-terminus structure 
could be recognized with the MAA functional monomers in the imprint created by 
the tetrapeptide template.  Success in the experiment may have come from the 
simplicity of peptide-surface interaction and small size of the binding molecules.  
For instance, the peptides used in Rachkova and Minourab’s study were 4-10 
amino acids in length, compared to lysozyme C peptide which was 18 amino 
acids in length.  In the present study, a large protein was used to test if a small 
peptide from its surface was able to bind, which is dissimilar to Rachkova and 
Minourab’s study where a small section of a peptide bound to imprints made from 
another peptide with a slightly smaller length. 
5.3.2. BMP-2 Imprinted Scaffolds 
 
BMP-2 was chosen as a template molecule for molecular imprinting in 
polysiloxane scaffolds because of its use as an important growth factor in the 
bone healing process [30].  Preferential binding of BMP-2 on imprinted polymers 
has the potential to be quite useful in applications where biomaterial compatibility 
and bone tissue growth are of importance.  It is hypothesized that when BMP-2 
imprinted polymers are implanted in a critical size bone defect, BMP-2 molecules 
released due to the wound healing response will have the greatest affinity for the 
imprinted crevices and adsorb on the surface.  This control of preferential binding 
could facilitate and expedite the cellular activity responsible for osteogenesis. 
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The results from the BMP-2 preferential binding tests showed more 
specific binding on scaffolds under noncompetitive conditions than for those with 
a protein ratio of 1:1 (BMP-2 to trypsin).  For both amount and percentage bound 
to the scaffolds, there was no statistical difference between the two types of 
protein that bound the surface.  While a very slight difference in the percentage 
bound can be seen in the results of Table 7, the standard deviation nullifies any 
conclusion of BMP-2 binding more than trypsin.  A large standard deviation is the 
result of a variation in scaffold properties.  Each scaffold is individually prepared, 
starting from the addition of protein during polymerization and ending with the 
grinding to make the shape as consistent as possible to the standard 
dimensions.  Because each scaffold will vary slightly in such details as initial 
protein amount, number of imprints, amount of available binding sites exposed to 
the surface, surface area, pore size, and porosity, the number of template as well 
as competitor molecules that bind will also vary.  This problem might be fixed 
using methods that eliminate individual manual processing.  New technologies 
are being explored in rapid prototyping such as solid free-form fabrication that 
may one day address this issue [60].  Another concern may have been the actual 
amount of protein added to the polymerization mix.  In previous experiments [54], 
much more than 30μg of protein was added to the polymerization mix.  
Significant preferential binding results using 100, 1000 and 3000μg were 
accomplished while using lysozyme.  The difficulty with using BMP-2 as a 
potential protein for molecular imprinting is that using amounts of 3000μg for 
multiple experiments would be unfeasible due to price and the exorbitant amount 
used. 
The amount of protein that bound the scaffold solely due to imprinting was 
found by subtracting the percent that bound to the non-imprinted scaffolds.  This 
gives negative values for trypsin binding amounts.  This means that the blank 
scaffolds bound higher quantities of trypsin than the imprinted scaffolds.  The 
negative value for trypsin binding to the scaffolds with a protein ratio of 0:1 
(template to competitor) is an interesting observation, as it suggests that the 
BMP-2 imprinted scaffolds may have a repelling effect on proteins that do not fit 
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into the special imprints.  In other words, the surface of the scaffolds is shielded 
from non-specific binding.  This observation is only seen with the trypsin 
competitor and not seen with binding of the RNase A.  This might suggest, as 
speculated, that the chemistry of the molecular imprint is not allowing for non-
specific binding of the trypsin to the polymer surface, similar to how the surface 
chemistry of biomaterial surfaces minimize non-specific binding of adhesion 
proteins upon contact with blood [26, 61].  Further studies would need to take 
place to assess whether this feature would be beneficial in tissue-material 
interactions.  Whether this phenomenon is desirable or not would depend on the 
results of such studies and its application as a biomaterial. 
Studies of BMP-2 adhesion on porous scaffolds for bone induction are not 
uncommon, and a limited release of the protein from the scaffolds is also 
observed.  For instance, BMP-2 released from porous calcium phosphate (Ca-P) 
cement was studied by Ruhé et al. to evaluate the scaffolds’ osteoinductive 
properties in rabbit cranial defects [62].  Unlike using silica polymers fabricated 
by the sol-gel process, the group utilized calcium phosphate cement with a 
carbon dioxide induction technique to create the porous scaffold.  An amount of 
10µg of BMP-2 (recombinant human or rhBMP-2) was adsorbed on the surface 
of the scaffolds by pipette.  Release profiles were carried out in an additional 
study to determine whether the bone formation was induced by a relatively high 
concentration of growth factor in the surrounding tissues.  The study revealed 
that only a limited release of the loaded rhBMP-2 (9.7 ± 0.9 %) had occurred 
cumulatively over a 28 day period.  These results along with the results of the 
present study suggest that the absorption properties of BMP-2 may still not be 
fully understood, and further study of the protein-material interface for BMP-2 is 
required for more efficient specific binding. 
5.4. Cytocompatibility 
 
The initial in vitro testing of the molecularly imprinted polysiloxane 
scaffolds for bone biomaterial applications involved ensuring that osteogenic 
cells had the ability to remain viable on the polymer surface under controlled 
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environments.  As a control to compare the polymer’s performance, cells were 
grown on tissue culture plastic on the bottom of the culture plates.  As with most 
tissue or cell culture plastic, cells are highly compatible with the surface due to its 
hydrophilic nature and good physical properties.  In this case cells would be able 
to adhere and spread on the surface very quickly, and in the few days following 
become a confluent multi-layered sheet.  The results of the cytocompatibility test 
are evidence that this is true (Figure 24).  After one day of incubation on the 
tissue culture plastic, a high amount of DNA content was recorded.  By day 3, the 
amount of cells on the surface was beginning to reach its capacity.  This can be 
assumed from the fact that by day 7 the amount of DNA content has not 
changed.  This behavior of cellular growth is compared to the pattern for growth 
on the polysiloxane scaffolds for effective cell viability. 
C3H growth on the polysiloxane scaffolds was measured at very small 
values.  While it was apparent that cells did exist on the surface of the scaffolds, 
substantial growth during the 1 week incubation period was not observed.  The 
DNA content decreased slightly during the 1-3 day interval and then increased up 
to day 7, however statistical analysis showed that there was no significant 
difference in growth at that time.  A few reasons could have accounted for the 
growth rate behavior of the cells on the polymer scaffolds.  The most apparent 
cause for such a large difference in cell growth existed between the tissue culture 
plastic and porous polymer was the different surface chemistry.  Tissue culture 
plastic is made of polystyrene that is oxidized to increase hydrophilicity, which 
results in abundant protein adsorption that enables cells to easily attach and 
spread out.  The surface of the polysiloxane on the other hand was mostly non-
polar due to the large influence of the stable TEOS cross-linker chemical, and 
may have been responsible for low cell attachment. 
Another possible cause for low cell adhesion could be that a very small 
number of cells were actually present on the scaffold surface once incubation 
began.  The cells were seeded on the polymer scaffolds in a very small volume 
of medium to achieve a high surface density of cells.  The scaffolds were then 
incubated for 2 hours to allow for the cells to infiltrate the pores and attach to the 
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surface.  If the cells are not all properly attached, addition of the 5mL of medium 
will cause them to lift off of the surface and into the surrounding solution.  Not all 
of the cells are able to fit on the top surface before the 2 hour incubation period, 
so even less therefore are able to grow and are measured after the 1 week time 
span.  The reason for this event may be due to the actual physical properties of 
the scaffolds.  In a study performed by Borden et al., osteoblasts cells were 
seeded on poly(lactide-co-glicolide) (PLAGA) sintered scaffolds.  The group was 
able to fabricate an “optimal scaffold” with a median pore size of 210μm and a 
porosity of 35% from heated microspheres [63].  They reported that after 7 and 
16 days, SEM results indicated that the cells had attached and proliferated 
through the microsphere pore system.  The polysiloxane scaffolds used for cell 
seeding in the present study had similar a porosity (43%) but a very small 
average pore size diameter (approximately 6.2μm).  Such a small pore size could 
be responsible for low cell infiltration during the 2 hour seed incubation period 
and therefore lead to cells washing off the surface of the scaffold during medium 
addition.  Cells that did wash off into the wells were observable under the light 
microscope, and throughout the entire incubation period appeared to be quite 
healthy.  This indicates that the reason for low DNA content might not be due to 
malevolent factors such as the release ethanol from the scaffolds or any changes 
in pH. 
Once it can be shown that cells were able to survive on the surface of the 
scaffolds, the next phase would be determining if cellular activity could be 
influenced by the preferential binding of BMP-2 on the imprinted scaffolds.  As an 
in vitro experiment, the system under control must simulate the cells’ natural 
environment as closely as possible until there is enough evidence that the 
material can perform well in vivo.  For molecularly imprinted polymers in the use 
of tissue engineered bone scaffolds, that possibility is coming steadily closer. 
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6. Conclusions 
The potential for protein imprinted polymers has been shown, as well as 
trends of the same preferential binding with the imprinting of peptides and 
biologically relevant proteins.  Fabrication of the scaffolds was accomplished 
using a sol-gel processing technique, which entrapped protein and water in the 
polymer matrix via siloxane bonds.  The scaffolds were characterized by the 
amount and number of protein molecules that released from the porous surface 
after proteolytic digestion with a protease enzyme mixture.  The unloading 
capacity on all scaffolds ranged from about 40% to 80%, which approximated the 
number of available binding sites on the scaffolds.  This value approximated the 
amount of protein that was re-exposed to test for preferential binding.  Lysozyme, 
a protein not important for bone formation, preferentially bound about 1.71 ± 
0.01μg.  Peptide imprinted scaffolds preferentially bound about 0.55 ± 2.95μg of 
the whole protein.  BMP-2 imprinted scaffolds preferentially rebound 0.075 ± 
0.52μg.  All were under competition of a protein that was similar in molecular 
weight, but different in chemistry.  Errors in the data produced large standard 
deviations, most of which were present because of large non-specific binding of 
the competitors on the imprinted scaffolds, protein conformation stability, 
fabrication and protein imprinting orientation issues.  While it is apparent that 
perfecting the art is still far away, there is evidence that molecularly imprinted 
polymers have the potential to be key players in the realm of protein and cell 
interactions for tissue engineering and biomaterial integration.  For further in vitro 
study, the viability and activity of cells on BMP-2 imprinted scaffolds, (both empty 
imprints and imprints with preferentially bound protein) for the control of cellular 
behavior, should be performed. 
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